Nasal Drug Delivery Technology Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Nasal Drug Delivery Technology Market to 2027 - Global Analysis and Forecasts By Systems ( Unit Dose, Bi-Dose, Multi Dose ); Containers ( Pressurized Containers, Non-Pressurized Containers ); Dosage Form ( Nasal Powders, Nasal Gels, Nasal Drops and Liquids, Nasal Spray, Others ); Therapeutic Application ( Allergic and Non-Allergic Rhinitis, Nasal Congestion, Vaccinations, Other Applications ); End User ( Hospitals, Home Health Care )

Report Code: TIPRE00003419 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Administration of drug through nasal route is an alternative of parenteral route which is also known as nasal drug delivery system. The nasal drug administration has been used as an alternative route for the systemic availability of drugs that are restricted to intravenous administration. This technology provides easy to administration, patient compliance, low dose requirement, bypass first pass metabolism, excellent penetration rapid absorption and gives desirable effects. Many drug delivery devices for nasal application of liquid, semisolid and solid formulation are investigated to deliver the drugs to the treat most CNS diseases such as, Parkinson's disease and Alzheimer's disease.

MARKET DYNAMICS
The nasal drug delivery technology market is anticipated to grow in the forecast period owing to driving factors such as, increasing demand for nasal drug delivery systems, technological advancement and growing incidence of chronic diseases. Moreover, growing adoption of self-administration practices is anticipated to offer more growth opportunities for the players operating in the nasal drug delivery technology market.

MARKET SCOPE
The "Global Nasal Drug Delivery Technology Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of nasal drug delivery technology market with detailed market segmentation by systems, containers, dosage form, therapeutic application, end user and geography. The global nasal drug delivery technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading nasal drug delivery technology market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global nasal drug delivery technology market is segmented on the basis of systems, containers, dosage form, therapeutic application and end user. Based on systems, the market is segmented as, unit dose, bi-dose and multi dose. On the basis of containers, the market is segmented into, pressurized containers and non-pressurized containers. Based on the dosage form, the nasal drug delivery technology market is classified as, nasal powders, nasal gels, nasal drops & liquids and nasal spray. On the basis of application, the global nasal drug delivery technology market is categorized as, allergic & non-allergic rhinitis, nasal congestion, vaccinations and other applications. Based on the end user, the global nasal drug delivery technology market is segmented into hospitals and home health care.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global nasal drug delivery technology market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nasal drug delivery technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nasal drug delivery technology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the nasal drug delivery technology market in these regions.

MARKET PLAYERS
The reports cover key developments in the nasal drug delivery technology market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from nasal drug delivery technology market are anticipated to lucrative growth opportunities in the future with the rising demand for nasal drug delivery technology market in the global market. Below mentioned is the list of few companies engaged in the nasal drug delivery technology market.

The report also includes the profiles of key nasal drug delivery technology market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Novartis AG
• Pfizer, Inc.
• Merck and Co., Inc.
• Glaxosmithkline PLC
• Johnson and Johnson Services, Inc.
• 3M
• BD
• Astrazeneca PLC
• Aegis Therapeutics, LLC
• Aptargroup, Inc.

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 NASAL DRUG DELIVERY TECHNOLOGY MARKET - By Systems
1.3.2 NASAL DRUG DELIVERY TECHNOLOGY MARKET - By Containers
1.3.3 NASAL DRUG DELIVERY TECHNOLOGY MARKET - By Dosage Form
1.3.4 NASAL DRUG DELIVERY TECHNOLOGY MARKET - By Therapeutic Application
1.3.5 NASAL DRUG DELIVERY TECHNOLOGY MARKET - By End User
1.3.6 NASAL DRUG DELIVERY TECHNOLOGY MARKET - By Region
1.3.6.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. NASAL DRUG DELIVERY TECHNOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. NASAL DRUG DELIVERY TECHNOLOGY MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NASAL DRUG DELIVERY TECHNOLOGY MARKET - GLOBAL MARKET ANALYSIS

6.1. NASAL DRUG DELIVERY TECHNOLOGY - GLOBAL MARKET OVERVIEW
6.2. NASAL DRUG DELIVERY TECHNOLOGY - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NASAL DRUG DELIVERY TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - SYSTEMS

7.1. OVERVIEW
7.2. SYSTEMS MARKET FORECASTS AND ANALYSIS
7.3. UNIT DOSE
7.3.1. Overview
7.3.2. Unit Dose Market Forecast and Analysis
7.4. BI-DOSE
7.4.1. Overview
7.4.2. Bi-Dose Market Forecast and Analysis
7.5. MULTI DOSE
7.5.1. Overview
7.5.2. Multi Dose Market Forecast and Analysis

8. NASAL DRUG DELIVERY TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - CONTAINERS

8.1. OVERVIEW
8.2. CONTAINERS MARKET FORECASTS AND ANALYSIS
8.3. PRESSURIZED CONTAINERS
8.3.1. Overview
8.3.2. Pressurized Containers Market Forecast and Analysis
8.4. NON-PRESSURIZED CONTAINERS
8.4.1. Overview
8.4.2. Non-Pressurized Containers Market Forecast and Analysis

9. NASAL DRUG DELIVERY TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM

9.1. OVERVIEW
9.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
9.3. NASAL POWDERS
9.3.1. Overview
9.3.2. Nasal Powders Market Forecast and Analysis
9.4. NASAL GELS
9.4.1. Overview
9.4.2. Nasal Gels Market Forecast and Analysis
9.5. NASAL DROPS AND LIQUIDS
9.5.1. Overview
9.5.2. Nasal Drops and Liquids Market Forecast and Analysis
9.6. NASAL SPRAY
9.6.1. Overview
9.6.2. Nasal Spray Market Forecast and Analysis
9.7. OTHERS
9.7.1. Overview
9.7.2. Others Market Forecast and Analysis

10. NASAL DRUG DELIVERY TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - THERAPEUTIC APPLICATION

10.1. OVERVIEW
10.2. THERAPEUTIC APPLICATION MARKET FORECASTS AND ANALYSIS
10.3. ALLERGIC AND NON-ALLERGIC RHINITIS
10.3.1. Overview
10.3.2. Allergic and Non-Allergic Rhinitis Market Forecast and Analysis
10.4. NASAL CONGESTION
10.4.1. Overview
10.4.2. Nasal Congestion Market Forecast and Analysis
10.5. VACCINATIONS
10.5.1. Overview
10.5.2. Vaccinations Market Forecast and Analysis
10.6. OTHER APPLICATIONS
10.6.1. Overview
10.6.2. Other Applications Market Forecast and Analysis

11. NASAL DRUG DELIVERY TECHNOLOGY MARKET - REVENUE AND FORECASTS TO 2027 - END USER

11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS
11.3.1. Overview
11.3.2. Hospitals Market Forecast and Analysis
11.4. HOME HEALTH CARE
11.4.1. Overview
11.4.2. Home Health Care Market Forecast and Analysis

12. NASAL DRUG DELIVERY TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

12.1. NORTH AMERICA
12.1.1 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Overview
12.1.2 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis
12.1.3 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Systems
12.1.4 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Containers
12.1.5 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Dosage Form
12.1.6 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Therapeutic Application
12.1.7 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By End User
12.1.8 North America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Countries
12.1.8.1 United States NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.1.8.1.1 United States NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.1.8.1.2 United States NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.1.8.1.3 United States NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.1.8.1.4 United States NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.1.8.1.5 United States NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.1.8.2 Canada NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.1.8.2.1 Canada NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.1.8.2.2 Canada NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.1.8.2.3 Canada NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.1.8.2.4 Canada NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.1.8.2.5 Canada NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.1.8.3 Mexico NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.1.8.3.1 Mexico NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.1.8.3.2 Mexico NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.1.8.3.3 Mexico NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.1.8.3.4 Mexico NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.1.8.3.5 Mexico NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.2. EUROPE
12.2.1 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Overview
12.2.2 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis
12.2.3 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Systems
12.2.4 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Containers
12.2.5 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Dosage Form
12.2.6 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Therapeutic Application
12.2.7 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By End User
12.2.8 Europe NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Countries
12.2.8.1 Germany NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.2.8.1.1 Germany NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.2.8.1.2 Germany NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.2.8.1.3 Germany NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.2.8.1.4 Germany NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.2.8.1.5 Germany NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.2.8.2 France NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.2.8.2.1 France NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.2.8.2.2 France NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.2.8.2.3 France NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.2.8.2.4 France NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.2.8.2.5 France NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.2.8.3 Italy NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.2.8.3.1 Italy NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.2.8.3.2 Italy NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.2.8.3.3 Italy NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.2.8.3.4 Italy NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.2.8.3.5 Italy NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.2.8.4 Spain NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.2.8.4.1 Spain NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.2.8.4.2 Spain NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.2.8.4.3 Spain NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.2.8.4.4 Spain NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.2.8.4.5 Spain NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.2.8.5 United Kingdom NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.2.8.5.1 United Kingdom NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.2.8.5.2 United Kingdom NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.2.8.5.3 United Kingdom NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.2.8.5.4 United Kingdom NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.2.8.5.5 United Kingdom NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Overview
12.3.2 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis
12.3.3 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Systems
12.3.4 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Containers
12.3.5 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Dosage Form
12.3.6 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Therapeutic Application
12.3.7 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By End User
12.3.8 Asia-Pacific NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Countries
12.3.8.1 Australia NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.3.8.1.1 Australia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.3.8.1.2 Australia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.3.8.1.3 Australia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.3.8.1.4 Australia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.3.8.1.5 Australia NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.3.8.2 China NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.3.8.2.1 China NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.3.8.2.2 China NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.3.8.2.3 China NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.3.8.2.4 China NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.3.8.2.5 China NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.3.8.3 India NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.3.8.3.1 India NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.3.8.3.2 India NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.3.8.3.3 India NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.3.8.3.4 India NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.3.8.3.5 India NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.3.8.4 Japan NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.3.8.4.1 Japan NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.3.8.4.2 Japan NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.3.8.4.3 Japan NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.3.8.4.4 Japan NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.3.8.4.5 Japan NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.3.8.5 South Korea NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.3.8.5.1 South Korea NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.3.8.5.2 South Korea NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.3.8.5.3 South Korea NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.3.8.5.4 South Korea NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.3.8.5.5 South Korea NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Overview
12.4.2 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis
12.4.3 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Systems
12.4.4 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Containers
12.4.5 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Dosage Form
12.4.6 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Therapeutic Application
12.4.7 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By End User
12.4.8 Middle East and Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Countries
12.4.8.1 South Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.4.8.1.1 South Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.4.8.1.2 South Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.4.8.1.3 South Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.4.8.1.4 South Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.4.8.1.5 South Africa NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.4.8.2 Saudi Arabia NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.4.8.2.1 Saudi Arabia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.4.8.2.2 Saudi Arabia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.4.8.2.3 Saudi Arabia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.4.8.2.4 Saudi Arabia NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.4.8.2.5 Saudi Arabia NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.4.8.3 U.A.E NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.4.8.3.1 U.A.E NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.4.8.3.2 U.A.E NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.4.8.3.3 U.A.E NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.4.8.3.4 U.A.E NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.4.8.3.5 U.A.E NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Overview
12.5.2 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis
12.5.3 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Systems
12.5.4 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Containers
12.5.5 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Dosage Form
12.5.6 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Therapeutic Application
12.5.7 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By End User
12.5.8 South and Central America NASAL DRUG DELIVERY TECHNOLOGY MARKET Forecasts and Analysis - By Countries
12.5.8.1 Brazil NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.5.8.1.1 Brazil NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.5.8.1.2 Brazil NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.5.8.1.3 Brazil NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.5.8.1.4 Brazil NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.5.8.1.5 Brazil NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User
12.5.8.2 Argentina NASAL DRUG DELIVERY TECHNOLOGY MARKET
12.5.8.2.1 Argentina NASAL DRUG DELIVERY TECHNOLOGY MARKET by Systems
12.5.8.2.2 Argentina NASAL DRUG DELIVERY TECHNOLOGY MARKET by Containers
12.5.8.2.3 Argentina NASAL DRUG DELIVERY TECHNOLOGY MARKET by Dosage Form
12.5.8.2.4 Argentina NASAL DRUG DELIVERY TECHNOLOGY MARKET by Therapeutic Application
12.5.8.2.5 Argentina NASAL DRUG DELIVERY TECHNOLOGY MARKET by End User

13. INDUSTRY LANDSCAPE

13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. NASAL DRUG DELIVERY TECHNOLOGY MARKET, KEY COMPANY PROFILES

14.1. NOVARTIS AG
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. PFIZER, INC.
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. MERCK AND CO., INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. GLAXOSMITHKLINE PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. JOHNSON AND JOHNSON SERVICES, INC.
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. 3M
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BD
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. ASTRAZENECA PLC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. AEGIS THERAPEUTICS, LLC
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. APTARGROUP, INC.
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX

15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Novartis AG
2. Pfizer, Inc.
3. Merck and Co., Inc.
4. Glaxosmithkline PLC
5. Johnson and Johnson Services, Inc.
6. 3M
7. BD
8. Astrazeneca PLC
9. Aegis Therapeutics, LLC
10. Aptargroup, Inc.